Table of Contents 1 Study Coverage 1.1 Peptides and Heparin Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Peptides and Heparin Market Size Growth Rate by Product 1.4.2 Insulin 1.4.3 Teriparatide 1.4.4 Liraglutide 1.4.5 Leuprolide 1.4.6 Leuprolide 1.4.7 Exenatide 1.4.8 Calcitonin 1.4.9 Enaxaparin Sodium 1.4.10 Heparin Sodium 1.5 Market by End User 1.5.1 Global Peptides and Heparin Market Size Growth Rate by End User 1.5.2 Diabetes 1.5.3 Infectious Diseases 1.5.4 Cancer 1.5.5 Osteoporosis 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Peptides and Heparin Market Size 2.1.1 Global Peptides and Heparin Revenue 2014-2025 2.1.2 Global Peptides and Heparin Sales 2014-2025 2.2 Peptides and Heparin Growth Rate by Regions 2.2.1 Global Peptides and Heparin Sales by Regions 2.2.2 Global Peptides and Heparin Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Peptides and Heparin Sales by Manufacturers 3.1.1 Peptides and Heparin Sales by Manufacturers 3.1.2 Peptides and Heparin Sales Market Share by Manufacturers 3.1.3 Global Peptides and Heparin Market Concentration Ratio (CR5 and HHI) 3.2 Peptides and Heparin Revenue by Manufacturers 3.2.1 Peptides and Heparin Revenue by Manufacturers (2014-2019) 3.2.2 Peptides and Heparin Revenue Share by Manufacturers (2014-2019) 3.3 Peptides and Heparin Price by Manufacturers 3.4 Peptides and Heparin Manufacturing Base Distribution, Product Types 3.4.1 Peptides and Heparin Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Peptides and Heparin Product Type 3.4.3 Date of International Manufacturers Enter into Peptides and Heparin Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Peptides and Heparin Sales by Product 4.2 Global Peptides and Heparin Revenue by Product 4.3 Peptides and Heparin Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Peptides and Heparin Breakdown Data by End User 6 North America 6.1 North America Peptides and Heparin by Countries 6.1.1 North America Peptides and Heparin Sales by Countries 6.1.2 North America Peptides and Heparin Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Peptides and Heparin by Product 6.3 North America Peptides and Heparin by End User 7 Europe 7.1 Europe Peptides and Heparin by Countries 7.1.1 Europe Peptides and Heparin Sales by Countries 7.1.2 Europe Peptides and Heparin Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Peptides and Heparin by Product 7.3 Europe Peptides and Heparin by End User 8 Asia Pacific 8.1 Asia Pacific Peptides and Heparin by Countries 8.1.1 Asia Pacific Peptides and Heparin Sales by Countries 8.1.2 Asia Pacific Peptides and Heparin Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Peptides and Heparin by Product 8.3 Asia Pacific Peptides and Heparin by End User 9 Central & South America 9.1 Central & South America Peptides and Heparin by Countries 9.1.1 Central & South America Peptides and Heparin Sales by Countries 9.1.2 Central & South America Peptides and Heparin Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Peptides and Heparin by Product 9.3 Central & South America Peptides and Heparin by End User 10 Middle East and Africa 10.1 Middle East and Africa Peptides and Heparin by Countries 10.1.1 Middle East and Africa Peptides and Heparin Sales by Countries 10.1.2 Middle East and Africa Peptides and Heparin Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Peptides and Heparin by Product 10.3 Middle East and Africa Peptides and Heparin by End User 11 Company Profiles 11.1 Cipla Ltd. 11.1.1 Cipla Ltd. Company Details 11.1.2 Company Business Overview 11.1.3 Cipla Ltd. Peptides and Heparin Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Cipla Ltd. Peptides and Heparin Products Offered 11.1.5 Cipla Ltd. Recent Development 11.2 Emcure Pharmaceuticals Pvt. Ltd. 11.2.1 Emcure Pharmaceuticals Pvt. Ltd. Company Details 11.2.2 Company Business Overview 11.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Products Offered 11.2.5 Emcure Pharmaceuticals Pvt. Ltd. Recent Development 11.3 Gland Pharma Limited 11.3.1 Gland Pharma Limited Company Details 11.3.2 Company Business Overview 11.3.3 Gland Pharma Limited Peptides and Heparin Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Gland Pharma Limited Peptides and Heparin Products Offered 11.3.5 Gland Pharma Limited Recent Development 11.4 Troikaa Pharmaceuticals Ltd. 11.4.1 Troikaa Pharmaceuticals Ltd. Company Details 11.4.2 Company Business Overview 11.4.3 Troikaa Pharmaceuticals Ltd. Peptides and Heparin Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Troikaa Pharmaceuticals Ltd. Peptides and Heparin Products Offered 11.4.5 Troikaa Pharmaceuticals Ltd. Recent Development 11.5 Biological E Limited 11.5.1 Biological E Limited Company Details 11.5.2 Company Business Overview 11.5.3 Biological E Limited Peptides and Heparin Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Biological E Limited Peptides and Heparin Products Offered 11.5.5 Biological E Limited Recent Development 11.6 Bharat Biotech 11.6.1 Bharat Biotech Company Details 11.6.2 Company Business Overview 11.6.3 Bharat Biotech Peptides and Heparin Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Bharat Biotech Peptides and Heparin Products Offered 11.6.5 Bharat Biotech Recent Development 11.7 Samarth Life Sciences Pvt. Ltd. 11.7.1 Samarth Life Sciences Pvt. Ltd. Company Details 11.7.2 Company Business Overview 11.7.3 Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Products Offered 11.7.5 Samarth Life Sciences Pvt. Ltd. Recent Development 11.8 VHB Life Sciences Limited 11.8.1 VHB Life Sciences Limited Company Details 11.8.2 Company Business Overview 11.8.3 VHB Life Sciences Limited Peptides and Heparin Sales, Revenue and Gross Margin (2014-2019) 11.8.4 VHB Life Sciences Limited Peptides and Heparin Products Offered 11.8.5 VHB Life Sciences Limited Recent Development 11.9 Celon Laboratories Pvt. Ltd. 11.9.1 Celon Laboratories Pvt. Ltd. Company Details 11.9.2 Company Business Overview 11.9.3 Celon Laboratories Pvt. Ltd. Peptides and Heparin Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Celon Laboratories Pvt. Ltd. Peptides and Heparin Products Offered 11.9.5 Celon Laboratories Pvt. Ltd. Recent Development 11.10 United Biotech (P) Limited 11.10.1 United Biotech (P) Limited Company Details 11.10.2 Company Business Overview 11.10.3 United Biotech (P) Limited Peptides and Heparin Sales, Revenue and Gross Margin (2014-2019) 11.10.4 United Biotech (P) Limited Peptides and Heparin Products Offered 11.10.5 United Biotech (P) Limited Recent Development 11.11 Biocon Limited 11.12 Sun Pharmaceutical Industries Ltd. 11.13 Wockhardt Ltd. 12 Future Forecast 12.1 Peptides and Heparin Market Forecast by Regions 12.1.1 Global Peptides and Heparin Sales Forecast by Regions 2019-2025 12.1.2 Global Peptides and Heparin Revenue Forecast by Regions 2019-2025 12.2 Peptides and Heparin Market Forecast by Product 12.2.1 Global Peptides and Heparin Sales Forecast by Product 2019-2025 12.2.2 Global Peptides and Heparin Revenue Forecast by Product 2019-2025 12.3 Peptides and Heparin Market Forecast by End User 12.4 North America Peptides and Heparin Forecast 12.5 Europe Peptides and Heparin Forecast 12.6 Asia Pacific Peptides and Heparin Forecast 12.7 Central & South America Peptides and Heparin Forecast 12.8 Middle East and Africa Peptides and Heparin Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Peptides and Heparin Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Peptides and Heparin Product Picture Table Peptides and Heparin Market Segments Table Key Manufacturers Peptides and Heparin Covered Table Global Peptides and Heparin Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$) Figure Global Peptides and Heparin Sales Market Share by Product 2014-2025 Figure Insulin Product Picture Table Major Manufacturers of Insulin Figure Teriparatide Product Picture Table Major Manufacturers of Teriparatide Figure Liraglutide Product Picture Table Major Manufacturers of Liraglutide Figure Leuprolide Product Picture Table Major Manufacturers of Leuprolide Figure Leuprolide Product Picture Table Major Manufacturers of Leuprolide Figure Exenatide Product Picture Table Major Manufacturers of Exenatide Figure Calcitonin Product Picture Table Major Manufacturers of Calcitonin Figure Enaxaparin Sodium Product Picture Table Major Manufacturers of Enaxaparin Sodium Figure Heparin Sodium Product Picture Table Major Manufacturers of Heparin Sodium Table Global Peptides and Heparin Market Size Growth Rate by End User 2019-2025 (K MT) Figure Diabetes Figure Infectious Diseases Figure Cancer Figure Osteoporosis Figure Peptides and Heparin Report Years Considered Figure Global Peptides and Heparin Market Size 2014-2025 (Million US$) Figure Global Peptides and Heparin Sales 2014-2025 (K MT) Table Global Peptides and Heparin Market Size by Regions 2014-2019 (K MT) & (Million US$) Table Global Peptides and Heparin Sales by Regions 2014-2019 (K MT) Table Global Peptides and Heparin Sales Market Share by Regions 2014-2019 Figure Global Peptides and Heparin Sales Market Share by Regions 2014-2019 Figure 2018 Global Peptides and Heparin Sales Market Share by Regions Table Global Peptides and Heparin Revenue by Regions 2014-2019 (Million US$) Table Global Peptides and Heparin Revenue Market Share by Regions 2014-2019 Figure Global Peptides and Heparin Revenue Market Share by Regions 2014-2019 Figure 2018 Global Peptides and Heparin Revenue Market Share by Regions Table Global Peptides and Heparin Sales by Manufacturers (2014-2019) (K MT) Table Global Peptides and Heparin Sales Share by Manufacturers (2014-2019) Figure Global Peptides and Heparin Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Peptides and Heparin Revenue by Manufacturers (2014-2019) (Million USD) Table Peptides and Heparin Revenue Share by Manufacturers (2014-2019) Figure Peptides and Heparin Value Share by Manufacturers in 2018 Table Key Manufacturers Peptides and Heparin Price (2014-2019) (USD/MT) Table Peptides and Heparin Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Peptides and Heparin Product Type Table Date of International Manufacturers Enter into Peptides and Heparin Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Peptides and Heparin Sales by Product (2014-2019) (K MT) Table Global Peptides and Heparin Sales Share by Product (2014-2019) Figure Global Peptides and Heparin Sales Market Share by Product (2014-2019) Figure Global Peptides and Heparin Sales Market Share by Product in 2018 Table Global Peptides and Heparin Revenue by Product (2014-2019) (Million US$) Table Global Peptides and Heparin Revenue Share by Product (2014-2019) Figure Global Peptides and Heparin Revenue Market Share by Product (2014-2019) Figure Global Peptides and Heparin Revenue Market Share by Product in 2018 Table Peptides and Heparin Price by Product 2014-2019 (USD/MT) Table Global Peptides and Heparin Sales by End User (2014-2019) (K MT) Table Global Peptides and Heparin Sales Share by End User (2014-2019) Figure Global Sales Peptides and Heparin Market Share by End User (2014-2019) Figure Global Sales Peptides and Heparin Market Share by End User in 2018 Figure North America Peptides and Heparin Sales Growth Rate 2014-2019 (K MT) Figure North America Peptides and Heparin Revenue Growth Rate 2014-2019 (Million US$) Table North America Peptides and Heparin Sales by Countries (2014-2019) (K MT) Table North America Peptides and Heparin Sales Market Share by Countries (2014-2019) Figure 2018 North America Peptides and Heparin Sales Market Share by Countries Table North America Peptides and Heparin Revenue by Countries (2014-2019) (Million US$) Table North America Peptides and Heparin Revenue Market Share by Countries (2014-2019) Figure 2018 North America Peptides and Heparin Revenue Market Share by Countries Figure United States Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure United States Peptides and Heparin Revenue Growth Rate (2014-2019) (K MT) Figure Canada Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Canada Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Mexico Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Table North America Peptides and Heparin Sales by Product (2014-2019) (K MT) Table North America Peptides and Heparin Sales Market Share by Product (2014-2019) Figure 2018 North America Peptides and Heparin Market Share by Product Table North America Peptides and Heparin Sales by End User (2014-2019) (K MT) Table North America Peptides and Heparin Sales Market Share by End User (2014-2019) Figure 2018 North America Peptides and Heparin Market Share by End User Figure Europe Peptides and Heparin Sales Growth Rate 2014-2019 (K MT) Figure Europe Peptides and Heparin Revenue Growth Rate 2014-2019 (Million US$) Table Europe Peptides and Heparin Sales by Countries (2014-2019) (K MT) Table Europe Peptides and Heparin Sales Market Share by Countries (2014-2019) Figure 2018 Europe Peptides and Heparin Sales Market Share by Countries Table Europe Peptides and Heparin Revenue by Countries (2014-2019) (Million US$) Table Europe Peptides and Heparin Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Peptides and Heparin Revenue Market Share by Countries Figure Germany Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Germany Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure France Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure France Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure UK Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure UK Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Italy Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Russia Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Table Europe Peptides and Heparin Sales by Product (2014-2019) (K MT) Table Europe Peptides and Heparin Sales Market Share by Product (2014-2019) Figure 2018 Europe Peptides and Heparin Market Share by Product Table Europe Peptides and Heparin Sales by End User (2014-2019) (K MT) Table Europe Peptides and Heparin Sales Market Share by End User (2014-2019) Figure 2018 Europe Peptides and Heparin Market Share by End User Figure Asia Pacific Peptides and Heparin Sales Growth Rate 2014-2019 (K MT) Figure Asia Pacific Peptides and Heparin Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Peptides and Heparin Sales by Countries (2014-2019) (K MT) Table Asia Pacific Peptides and Heparin Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Peptides and Heparin Sales Market Share by Countries Table Asia Pacific Peptides and Heparin Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Peptides and Heparin Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Peptides and Heparin Revenue Market Share by Countries Figure China Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure China Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Japan Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Korea Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure India Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure India Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Australia Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Indonesia Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Malaysia Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Philippines Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Thailand Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Vietnam Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Singapore Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Peptides and Heparin Sales by Product (2014-2019) (K MT) Table Asia Pacific Peptides and Heparin Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Peptides and Heparin Market Share by Product Table Asia Pacific Peptides and Heparin Sales by End User (2014-2019) (K MT) Table Asia Pacific Peptides and Heparin Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Peptides and Heparin Market Share by End User Figure Central & South America Peptides and Heparin Sales Growth Rate 2014-2019 (K MT) Figure Central & South America Peptides and Heparin Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Peptides and Heparin Sales by Countries (2014-2019) (K MT) Table Central & South America Peptides and Heparin Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Peptides and Heparin Sales Market Share by Countries Table Central & South America Peptides and Heparin Revenue by Countries (2014-2019) (Million US$) Table Central & South America Peptides and Heparin Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Peptides and Heparin Revenue Market Share by Countries Figure Brazil Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Brazil Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Argentina Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Peptides and Heparin Sales by Product (2014-2019) (K MT) Table Central & South America Peptides and Heparin Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Peptides and Heparin Market Share by Product Table Central & South America Peptides and Heparin Sales by End User (2014-2019) (K MT) Table Central & South America Peptides and Heparin Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Peptides and Heparin Market Share by End User Figure Middle East and Africa Peptides and Heparin Sales Growth Rate 2014-2019 (K MT) Figure Middle East and Africa Peptides and Heparin Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Peptides and Heparin Sales by Countries (2014-2019) (K MT) Table Middle East and Africa Peptides and Heparin Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Peptides and Heparin Sales Market Share by Countries Table Middle East and Africa Peptides and Heparin Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Peptides and Heparin Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Peptides and Heparin Revenue Market Share by Countries Figure GCC Countries Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure GCC Countries Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Turkey Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure Egypt Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Peptides and Heparin Sales Growth Rate (2014-2019) (K MT) Figure South Africa Peptides and Heparin Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Peptides and Heparin Sales by Product (2014-2019) (K MT) Table Middle East and Africa Peptides and Heparin Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Peptides and Heparin Market Share by Product Table Middle East and Africa Peptides and Heparin Sales by End User (2014-2019) (K MT) Table Middle East and Africa Peptides and Heparin Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Peptides and Heparin Market Share by End User Table Cipla Ltd. Company Details Table Cipla Ltd. Peptides and Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019) Table Cipla Ltd. Recent Development Table Emcure Pharmaceuticals Pvt. Ltd. Company Details Table Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019) Table Emcure Pharmaceuticals Pvt. Ltd. Recent Development Table Gland Pharma Limited Company Details Table Gland Pharma Limited Peptides and Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019) Table Gland Pharma Limited Recent Development Table Troikaa Pharmaceuticals Ltd. Company Details Table Troikaa Pharmaceuticals Ltd. Peptides and Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019) Table Troikaa Pharmaceuticals Ltd. Recent Development Table Biological E Limited Company Details Table Biological E Limited Peptides and Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019) Table Biological E Limited Recent Development Table Bharat Biotech Company Details Table Bharat Biotech Peptides and Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019) Table Bharat Biotech Recent Development Table Samarth Life Sciences Pvt. Ltd. Company Details Table Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019) Table Samarth Life Sciences Pvt. Ltd. Recent Development Table VHB Life Sciences Limited Company Details Table VHB Life Sciences Limited Peptides and Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019) Table VHB Life Sciences Limited Recent Development Table Celon Laboratories Pvt. Ltd. Company Details Table Celon Laboratories Pvt. Ltd. Peptides and Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019) Table Celon Laboratories Pvt. Ltd. Recent Development Table United Biotech (P) Limited Company Details Table United Biotech (P) Limited Peptides and Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019) Table United Biotech (P) Limited Recent Development Table Biocon Limited Company Details Table Sun Pharmaceutical Industries Ltd. Company Details Table Wockhardt Ltd. Company Details Table Global Peptides and Heparin Sales Forecast by Regions 2019-2025 (K MT) Table Global Peptides and Heparin Sales Market Share Forecast by Regions 2019-2025 Table Global Peptides and Heparin Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Peptides and Heparin Revenue Market Share Forecast by Regions 2019-2025 Table Global Peptides and Heparin Sales Forecast by Product 2019-2025 (K MT) Table Global Peptides and Heparin Sales Market Share Forecast by Product 2019-2025 Table Global Peptides and Heparin Revenue Forecast by Product 2019-2025 (Million US$) Table Global Peptides and Heparin Revenue Market Share Forecast by Product 2019-2025 Table Global Peptides and Heparin Sales Forecast by End User 2019-2025 (K MT) Table Global Peptides and Heparin Sales Market Share Forecast by End User 2019-2025 Figure North America Peptides and Heparin Sales Growth Rate Forecast (2019-2025) (K MT) Figure North America Peptides and Heparin Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Peptides and Heparin Sales Growth Rate Forecast (2019-2025) (K MT) Figure Europe Peptides and Heparin Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Peptides and Heparin Sales Growth Rate Forecast (2019-2025) (K MT) Figure Asia Pacific Peptides and Heparin Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Peptides and Heparin Sales Growth Rate Forecast (2019-2025) (K MT) Figure Central & South America Peptides and Heparin Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Peptides and Heparin Sales Growth Rate Forecast (2019-2025) (K MT) Figure Middle East and Africa Peptides and Heparin Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Peptides and Heparin Value Chain Table Peptides and Heparin Customers List Table Peptides and Heparin Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Cipla Ltd. Emcure Pharmaceuticals Pvt. Ltd. Gland Pharma Limited Troikaa Pharmaceuticals Ltd. Biological E Limited Bharat Biotech Samarth Life Sciences Pvt. Ltd. VHB Life Sciences Limited Celon Laboratories Pvt. Ltd. United Biotech (P) Limited Biocon Limited Sun Pharmaceutical Industries Ltd. Wockhardt Ltd.